NVCT Nuvectis Pharma, Inc.
Nasdaq · SEC CIK 1875558 · EDGAR
- Bought, last 12 months
- $2.29M 6 purchases by 4 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 130 since 2022-02-08, latest 2026-08-05 17:26
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Mosseri Marlio Charles | 10% | $1.87M | — |
| BENTSUR RON | COB, CEO, Dir, 10% | $278.6K | — |
| Sanchez Juan | Dir | $75.3K | — |
| Kaplan Matthew L. | Dir | $64.2K | — |
| Poradosu Enrique | Chief Science, Business Off | — | — |
| Carson Michael J. | VP, Fin | — | — |
| Shemesh Shay | Chief Dev, Ops. Off | — | — |
| Hoberman Kenneth | Dir | — | — |
| Oliviero James F III | Dir | — | — |
Transactions 128
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-06 | 2022-09-01+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $8.29 | +1,700 | 3.01M | +0.1% | +$14.1K |
| M | 2022-09-02 | 2022-08-31+ | NVCT | Shemesh Shay | Chief Dev, Ops. Off | P - Purchase | $8.07 | +3,006 | 1.24M | +0.2% | +$24.3K |
| M | 2022-08-30 | 2022-08-23+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $9.05 | +1,500 | 3.01M | +0.0% | +$13.6K |
| M | 2022-08-22 | 2022-08-18+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $8.69 | +19.4K | 3.01M | +0.7% | +$168.7K |
| 2022-08-16 | 2022-08-11 | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $8.40 | +19.7K | 2.99M | +0.7% | +$165.2K | |
| M | 2022-06-30 | 2022-06-28+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $11.63 | +4,000 | 2.96M | +0.1% | +$46.5K |
| M | 2022-06-27 | 2022-06-22+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $12.09 | +700 | 2.96M | +0.0% | +$8,462 |
| M | 2022-05-31 | 2022-05-26+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $15.82 | +1,000 | 2.96M | +0.0% | +$15.8K |
| M | 2022-05-23 | 2022-05-19+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $16.73 | +1,200 | 2.96M | +0.0% | +$20.1K |
| 2022-05-23 | 2022-05-20 | NVCT | Shemesh Shay | Chief Dev, Ops. Off | P - Purchase | $16.54 | +300 | 1.24M | +0.0% | +$4,962 | |
| M | 2022-05-19 | 2022-05-17+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $19.48 | +2,010 | 2.96M | +0.1% | +$39.2K |
| M | 2022-05-18 | 2022-05-16+ | NVCT | Shemesh Shay | Chief Dev, Ops. Off | P - Purchase | $19.44 | +242 | 1.24M | +0.0% | +$4,704 |
| M | 2022-05-17 | 2022-05-13+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $18.82 | +1,700 | 2.96M | +0.1% | +$32.0K |
| 2022-05-16 | 2022-05-12 | NVCT | Hoberman Kenneth | Dir | P - Purchase | $17.40 | +6,000 | 55.1K | +12% | +$104.4K | |
| M | 2022-05-16 | 2022-05-12 | NVCT | Kaplan Matthew L. | Dir | P - Purchase | $16.88 | +3,000 | 35.8K | +9% | +$50.6K |
| M | 2022-05-16 | 2022-05-12 | NVCT | Poradosu Enrique | Chief Science, Business Off | P - Purchase | $15.33 | +670 | 1.26M | +0.1% | +$10.3K |
| M | 2022-05-13 | 2022-05-12 | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $16.99 | +12.2K | 2.95M | +0.4% | +$208.0K |
| M | 2022-05-13 | 2022-05-12 | NVCT | Shemesh Shay | Chief Dev, Ops. Off | P - Purchase | $15.85 | +1,278 | 1.24M | +0.1% | +$20.3K |
| 2022-04-05 | 2022-04-01 | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | A - Grant | $0.00 | +120.0K | 2.95M | +4% | $0 | |
| 2022-04-05 | 2022-04-01 | NVCT | Shemesh Shay | Chief Dev, Ops. Off | A - Grant | $0.00 | +60.0K | 1.24M | +5% | $0 | |
| 2022-04-05 | 2022-04-01 | NVCT | Poradosu Enrique | Chief Science, Business Off | A - Grant | $0.00 | +60.0K | 1.26M | +5% | $0 | |
| 2022-03-29 | 2022-03-28 | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $7.05 | +4,000 | 2.83M | +0.1% | +$28.2K | |
| 2022-03-18 | 2022-03-17 | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $7.63 | +7,000 | 2.82M | +0.2% | +$53.4K | |
| 2022-02-15 | 2022-02-14 | NVCT | BENTSUR RON | COB, CEO, Dir | P - Purchase | $5.88 | +8,000 | 2.81M | +0.3% | +$47.0K | |
| 2022-02-11 | 2022-02-10 | NVCT | BENTSUR RON | COB, CEO, Dir | P - Purchase | $6.34 | +8,500 | 2.81M | +0.3% | +$53.9K | |
| M | 2022-02-08 | 2022-02-04+ | NVCT | BENTSUR RON | COB, CEO, Dir | P - Purchase | $4.96 | +232.5K | 2.78M | +9% | +$1.15M |
| M | 2022-02-08 | 2022-02-04+ | NVCT | Poradosu Enrique | Chief Science, Business Off | P - Purchase | $3.44 | +4,600 | 1.20M | +0.4% | +$15.8K |
| M | 2022-02-08 | 2022-02-04+ | NVCT | Shemesh Shay | Chief Development Off | P - Purchase | $3.41 | +2,946 | 1.18M | +0.3% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations